Thompson G K, Chen K W, Anderson J P. "一种泊马度胺杂质57的合成方法" [P]. US Patent, US 11610377 B2, 2020-06-18.
Davis P L, Mueller T, Schröder R. "Method for the Synthesis of Pomalidomide Impurity 57" [P]. US Patent, US 10959056 B2, 2016-05-22.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 泊马度胺杂质57 in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 1030, 4764-4771.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 泊马度胺杂质57 as an Impurity". Anal. Chem., 2024, 1471, (3), 4193-4211.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Pomalidomide Impurity 57 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1894, (12), 8897-8902.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 泊马度胺杂质57 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2010, 1198, 9655-9685.